Global Obesity Intervention Devices Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Obesity Intervention Devices Market Insights, Forecast to 2034
Obesity is a medical condition caused by an increase in fat cells in the body, which can have a negative impact on health. High blood pressure, high cholesterol and heart disease are serious medical conditions associated with obesity. Obesity also increases the risk of certain diseases, such as type 2 diabetes, osteoarthritis, obstructive sleep apnea, and depression. If diet or exercise is not effective, obesity intervention devices can be used to reduce the size of the stomach or the length of the intestine, thereby reducing the ability to absorb nutrients from food.
Market Analysis and InsightsGlobal Obesity Intervention Devices Market
Global Obesity Intervention Devices market is expected to reach to US$ 290 million in 2023, with a positive growth of %, compared with US$ 272 million in 2022. Backed with the increasing demand from downstream industries, Obesity Intervention Devices industry is evaluated to reach US$ 427.9 million in 2033. The CAGR will be 6.7% during 2023 to 2033.
According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.
Report Covers
This report presents an overview of global Obesity Intervention Devices market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Obesity Intervention Devices market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Medtronic
EnteroMedics
Apollo Endosurgery
Cousin Biotech
Aspire Bariatrics
Obalon Therapeutics
GI Dynamics
Johnson and Johnson
Spatz FGIA
Gore Medical
ReShape Lifesciences
Segment by Type
Gastric Bands
Electrical Stimulation System
Gastric Balloon System
Gastric Emptying System
Appetite Suppressors
Hospitals
Gastroenterology clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Obesity Intervention Devices introduction, etc. Obesity Intervention Devices Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Obesity Intervention Devices
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Obesity Intervention Devices Market
Global Obesity Intervention Devices market is expected to reach to US$ 290 million in 2023, with a positive growth of %, compared with US$ 272 million in 2022. Backed with the increasing demand from downstream industries, Obesity Intervention Devices industry is evaluated to reach US$ 427.9 million in 2033. The CAGR will be 6.7% during 2023 to 2033.
According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.
Report Covers
This report presents an overview of global Obesity Intervention Devices market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Obesity Intervention Devices market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Medtronic
EnteroMedics
Apollo Endosurgery
Cousin Biotech
Aspire Bariatrics
Obalon Therapeutics
GI Dynamics
Johnson and Johnson
Spatz FGIA
Gore Medical
ReShape Lifesciences
Segment by Type
Gastric Bands
Electrical Stimulation System
Gastric Balloon System
Gastric Emptying System
Appetite Suppressors
Segment by Application
Hospitals
Gastroenterology clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Obesity Intervention Devices introduction, etc. Obesity Intervention Devices Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Obesity Intervention Devices
Chapter 13Methodology and Data Sources adopted by MRAResearch